Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients
Med Clin (Engl Ed)
.
2023 May 26;160(10):458-459.
doi: 10.1016/j.medcle.2023.04.007.
Epub 2023 May 3.
Authors
María Fernández-Prada
1
,
Jaime Jesús Pérez-Martín
2
,
Paula Cienfuegos-González
1
Affiliations
1
Servicio de Medicina Preventiva y Salud Pública, Hospital Vital Álvarez Buylla, Mieres, Asturias, Spain.
2
Subdirector General de Salud Pública, Consejería de Salud de la Región de Murcia, Murcia, Spain.
PMID:
37207077
PMCID:
PMC10155831
DOI:
10.1016/j.medcle.2023.04.007
No abstract available
Publication types
Case Reports